Strategic partnerships Opportunity to engage with major health systems and regional collaboratives evidenced by past partnerships with Alberta Health Services and participation in MedTech Innovator; target hospitals and stroke centers to pilot SignalNED for rapid stroke screening.

Clinical validation Leverage demonstrated study results and awards to build credibility with procurement teams; present positive AlphaStroke study outcomes and MedTech Innovator recognition to accelerate conversations with stroke programs.

Telemedicine integration Position SignalNED as a portable, field-ready EEG tool that complements remote or rural care pathways; approach accountable care organizations and EMS networks focusing on pre-hospital stroke detection and early triage.

Cost and outcomes Highlight potential to reduce hospital burden and post-stroke care costs through faster, accurate decisions; craft ROI case studies for hospital CFOs and health plan committees.

Funding and growth With a seed and early-stage funding history and remaining growth potential, pursue strategic investors and larger medical device distributors to scale commercialization and expand market reach.